Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

BGI Shenzhen Buys Complete Genomics of the US for $117 Million

publication date: Sep 17, 2012
China’s BGI, the world’s largest sequencing company, paid $117 million to buy Complete Genomics, a California-based gene sequencing company. Complete Genomics owns a platform technology for sequencing whole human genomes. Although scientists appreciated the quality and completeness of Complete Genomics’ work, competitors could supply adequate amounts of information at a lower price. As a result, the company put itself up for sale at the beginning of the summer. By purchasing Complete Genomics, BGI has acquired another platform, and it has also extended its footprint in the US. More details....

Stock Symbol: (NSDQ: GNOM)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital